Detalles de la búsqueda
1.
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Proc Natl Acad Sci U S A;
121(17): e2321898121, 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38625939
2.
Extrauterine epithelioid trophoblastic tumour and its somatic carcinoma mimics: short tandem repeat genotyping meets the diagnostic challenges.
Histopathology;
84(2): 325-335, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743102
3.
Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications.
Int J Gynecol Pathol;
2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38426544
4.
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Proc Natl Acad Sci U S A;
118(15)2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33876771
5.
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression.
Gynecol Oncol;
170: 38-45, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610380
6.
Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma.
Gynecol Oncol;
168: 157-165, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36442427
7.
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
Gynecol Oncol;
169: 98-105, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525930
8.
Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
Gynecol Oncol;
172: 65-71, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36958197
9.
Anastomosing Hemangioma of the Ovary With Leydig Cell Hyperplasia: A Clinicopathologic Study of 12 Cases.
Int J Gynecol Pathol;
42(2): 167-175, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35512214
10.
Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas.
Int J Gynecol Pathol;
42(6): 567-575, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36730675
11.
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Cancer;
128(6): 1206-1218, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875107
12.
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Br J Cancer;
126(12): 1695-1703, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35149854
13.
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
Gynecol Oncol;
166(2): 351-357, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641325
14.
Dataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Int J Gynecol Pathol;
41(Suppl 1): S34-S43, 2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305533
15.
HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma.
Int J Gynecol Pathol;
41(2): 132-141, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33782344
16.
Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Int J Gynecol Pathol;
41(Suppl 1): S90-S118, 2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305536
17.
Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors.
Semin Diagn Pathol;
39(1): 58-77, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750021
18.
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
Proc Natl Acad Sci U S A;
116(2): 619-624, 2019 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30584090
19.
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
Proc Natl Acad Sci U S A;
116(45): 22730-22736, 2019 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31624127
20.
Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.
Mod Pathol;
34(9): 1658-1672, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34088998